First author, year | Trial design | Follow-up, years | Cumulative total, percent | |
No RT | RT | |||
Sarcoma | ||||
Taghian A; 1991 | Cohort* | 10 | – | 0.2 |
20 | 0.4 | |||
30 | 0.8 | |||
Obedian E; 2000 | Nonrandomized, cohort* | 15 | 0.2 | 0.4 |
Galper S; 2002 | Cohort* | 11 | – | 0.4 |
Yap J; 2002 | Case-control¶ | 15 | 0.2 | 0.3 |
Huang J; 2001 | Cohort | – | 0.07 | 0.13 |
Kirova Y; 2005 | Retrospective | 5 | 0.07 | |
10 | 0.27 | |||
15 | 0.48 | |||
Angiosarcoma | ||||
Marchal C; 1999 | Retrospective | – | 0.05 | |
Strobbe L; 1998 | Retrospective | – | 0.2 | |
Huang J; 2001 | Cohort | – | 0.005 | 0.08 |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟